Your browser doesn't support javascript.
loading
The CD94/NKG2A inhibitory receptor educates uterine NK cells to optimize pregnancy outcomes in humans and mice.
Shreeve, Norman; Depierreux, Delphine; Hawkes, Delia; Traherne, James A; Sovio, Ulla; Huhn, Oisin; Jayaraman, Jyothi; Horowitz, Amir; Ghadially, Hormas; Perry, John R B; Moffett, Ashley; Sled, John G; Sharkey, Andrew M; Colucci, Francesco.
Afiliação
  • Shreeve N; Department of Obstetrics & Gynaecology, University of Cambridge, National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 0SW, UK; University of Cambridge Centre for Trophoblast Research, Cambridge, UK.
  • Depierreux D; Department of Obstetrics & Gynaecology, University of Cambridge, National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 0SW, UK; University of Cambridge Centre for Trophoblast Research, Cambridge, UK.
  • Hawkes D; Department of Obstetrics & Gynaecology, University of Cambridge, National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 0SW, UK.
  • Traherne JA; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Sovio U; Department of Obstetrics & Gynaecology, University of Cambridge, National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 0SW, UK; University of Cambridge Centre for Trophoblast Research, Cambridge, UK.
  • Huhn O; Department of Obstetrics & Gynaecology, University of Cambridge, National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 0SW, UK; University of Cambridge Centre for Trophoblast Research, Cambridge, UK; Department of Pathology, University of Cambridge, Cambridge
  • Jayaraman J; University of Cambridge Centre for Trophoblast Research, Cambridge, UK; Department of Pathology, University of Cambridge, Cambridge, UK; Department of Physiology, Development and Neurobiology, University of Cambridge, Cambridge, UK.
  • Horowitz A; Department of Oncological Sciences, Precision Immunology Institute and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Ghadially H; AstraZeneca, Granta Park, Cambridge CB21 6GH, UK.
  • Perry JRB; MRC Epidemiology Unit, University of Cambridge, Cambridge UK.
  • Moffett A; University of Cambridge Centre for Trophoblast Research, Cambridge, UK; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Sled JG; Department of Medical Biophysics, University of Toronto, Toronto, Canada; Translational Medicine, Hospital for Sick Children, Toronto, Canada.
  • Sharkey AM; University of Cambridge Centre for Trophoblast Research, Cambridge, UK; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Colucci F; Department of Obstetrics & Gynaecology, University of Cambridge, National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 0SW, UK; University of Cambridge Centre for Trophoblast Research, Cambridge, UK. Electronic address: fc287@medschl.cam.ac.uk.
Immunity ; 54(6): 1231-1244.e4, 2021 06 08.
Article em En | MEDLINE | ID: mdl-33887202
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Útero / Células Matadoras Naturais / Subfamília D de Receptores Semelhantes a Lectina de Células NK / Subfamília C de Receptores Semelhantes a Lectina de Células NK Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Útero / Células Matadoras Naturais / Subfamília D de Receptores Semelhantes a Lectina de Células NK / Subfamília C de Receptores Semelhantes a Lectina de Células NK Idioma: En Ano de publicação: 2021 Tipo de documento: Article